These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 12411414
21. Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response. Hermann H, De Petrocellis L, Bisogno T, Schiano Moriello A, Lutz B, Di Marzo V. Cell Mol Life Sci; 2003 Mar; 60(3):607-16. PubMed ID: 12737320 [Abstract] [Full Text] [Related]
23. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. Ross RA, Gibson TM, Brockie HC, Leslie M, Pashmi G, Craib SJ, Di Marzo V, Pertwee RG. Br J Pharmacol; 2001 Feb; 132(3):631-40. PubMed ID: 11159715 [Abstract] [Full Text] [Related]
24. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta. Herradón E, Martín MI, López-Miranda V. Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831 [Abstract] [Full Text] [Related]
25. VR1-mediated depressor effects during high-salt intake: role of anandamide. Wang Y, Kaminski NE, Wang DH. Hypertension; 2005 Oct; 46(4):986-91. PubMed ID: 16144988 [Abstract] [Full Text] [Related]
26. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors. Moezi L, Gaskari SA, Liu H, Baik SK, Dehpour AR, Lee SS. Br J Pharmacol; 2006 Dec; 149(7):898-908. PubMed ID: 17043671 [Abstract] [Full Text] [Related]
27. Effects of anandamide and noxious heat on intracellular calcium concentration in nociceptive drg neurons of rats. Fischbach T, Greffrath W, Nawrath H, Treede RD. J Neurophysiol; 2007 Aug; 98(2):929-38. PubMed ID: 17581853 [Abstract] [Full Text] [Related]
29. Temperature-dependent activation of recombinant rat vanilloid VR1 receptors expressed in HEK293 cells by capsaicin and anandamide. Sprague J, Harrison C, Rowbotham DJ, Smart D, Lambert DG. Eur J Pharmacol; 2001 Jul 06; 423(2-3):121-5. PubMed ID: 11448475 [Abstract] [Full Text] [Related]
30. Mechanisms underlying tissue selectivity of anandamide and other vanilloid receptor agonists. Andersson DA, Adner M, Högestätt ED, Zygmunt PM. Mol Pharmacol; 2002 Sep 06; 62(3):705-13. PubMed ID: 12181448 [Abstract] [Full Text] [Related]
31. A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus. Craib SJ, Ellington HC, Pertwee RG, Ross RA. Br J Pharmacol; 2001 Sep 06; 134(1):30-7. PubMed ID: 11522594 [Abstract] [Full Text] [Related]
32. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. Di Marzo V, Lastres-Becker I, Bisogno T, De Petrocellis L, Milone A, Davis JB, Fernandez-Ruiz JJ. Eur J Pharmacol; 2001 May 25; 420(2-3):123-31. PubMed ID: 11408034 [Abstract] [Full Text] [Related]
33. Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide. Vellani V, Mapplebeck S, Moriondo A, Davis JB, McNaughton PA. J Physiol; 2001 Aug 01; 534(Pt 3):813-25. PubMed ID: 11483711 [Abstract] [Full Text] [Related]
34. Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence. de Lago E, de Miguel R, Lastres-Becker I, Ramos JA, Fernández-Ruiz J. Brain Res; 2004 May 08; 1007(1-2):152-9. PubMed ID: 15064146 [Abstract] [Full Text] [Related]
35. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse. Lay L, Angus JA, Wright CE. Eur J Pharmacol; 2000 Mar 10; 391(1-2):151-61. PubMed ID: 10720647 [Abstract] [Full Text] [Related]
36. Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. Tognetto M, Amadesi S, Harrison S, Creminon C, Trevisani M, Carreras M, Matera M, Geppetti P, Bianchi A. J Neurosci; 2001 Feb 15; 21(4):1104-9. PubMed ID: 11160380 [Abstract] [Full Text] [Related]
37. Cannabidiol lacks the vanilloid VR1-mediated vasorespiratory effects of capsaicin and anandamide in anaesthetised rats. McQueen DS, Bond SM, Smith PJ, Balali-Mood K, Smart D. Eur J Pharmacol; 2004 May 03; 491(2-3):181-9. PubMed ID: 15140635 [Abstract] [Full Text] [Related]
38. Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. Marinelli S, Di Marzo V, Berretta N, Matias I, Maccarrone M, Bernardi G, Mercuri NB. J Neurosci; 2003 Apr 15; 23(8):3136-44. PubMed ID: 12716921 [Abstract] [Full Text] [Related]
39. Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors. Brooks JW, Pryce G, Bisogno T, Jaggar SI, Hankey DJ, Brown P, Bridges D, Ledent C, Bifulco M, Rice AS, Di Marzo V, Baker D. Eur J Pharmacol; 2002 Mar 29; 439(1-3):83-92. PubMed ID: 11937096 [Abstract] [Full Text] [Related]
40. Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation. Patel HJ, Birrell MA, Crispino N, Hele DJ, Venkatesan P, Barnes PJ, Yacoub MH, Belvisi MG. Br J Pharmacol; 2003 Sep 29; 140(2):261-8. PubMed ID: 12970104 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]